News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Danuglipron helps with glucose control, weight loss in T2D
15 Jul 2023
byJairia Dela Cruz
The glucagon-like peptide 1 receptor (GLP-1R) agonist danuglipron appears to be beneficial in the treatment of patients with type 2 diabetes (T2D), yielding reductions in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), and body weight, without fasting restrictions, as shown in the results of a phase IIb study.
15 Jul 2023







